The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence‐based clinical guidelines
Open accessAbstract
Radiotherapy utilization rates for cancer vary widely internationally. It has previously been suggested that approximately 50% of all cancer patients should receive radiation. However, this estimate was not evidence‐based. The aim of this study was to estimate the ideal proportion of new cases of cancer that should receive radiotherapy at least once during the course of their illness based on the best available evidence. An optimal radiotherapy utilization tree was constructed for each cancer based upon indications for radiotherapy taken from evidence‐based treatment guidelines. The proportion of patients with clinical attributes that indicated a possible benefit from radiotherapy was obtained by adding epidemiologic data to the radiotherapy utilization tree. The optimal proportion of patients with cancer that should receive radiotherapy was then calculated using TreeAge (TreeAge Software, Williamstown, MA) software. Sensitivity analyses using univariate analysis and Monte Carlo simulations were performed. The proportion of patients with cancer in whom external beam radiotherapy is indicated according to the best available evidence was calculated to be 52%. Monte Carlo analysis indicated that the 95% confidence limits were from 51.7% to 53.1%. The tightness of the confidence interval suggests that the overall estimate is robust. Comparison with actual radiotherapy utilization data suggests a shortfall in actual radiotherapy delivery. This methodology allows comparison of optimal rates with actual rates to identify areas where improvements in the evidence‐based use of radiotherapy can be made. It provides valuable data for radiotherapy service planning. Actual rates need to be addressed to ensure better radiotherapy utilization. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines
(1999) · PsycEXTRA Dataset · doi:10.1037/e508692012-001 · Cited by 527
Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach
Tyldesley, S., Boyd, C., Schulze, K., Walker, H., & Mackillop, W. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01401-2 · Cited by 224
Does a centralized radiotherapy system provide adequate access to care?
Mackillop, W. J., Groome, P. A., Zhang-Solomons, J., Zhou, Y., Feldman‐Stewart, D., Paszat, L. F., Dixon, P., Holowaty, E. J., & Cummings, B. J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1261 · Cited by 119
A model for decision making for the use of radiotherapy in lung cancer
Delaney, G. P., Barton, M. B., Jacob, S., et al. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)00984-7 · Cited by 110
Self-citationA Prospective Survey of Radiotherapy Practice 2001 in Sweden
Möller, T. R., Brorsson, B., Ceberg, J., et al. (2003) · Acta Oncologica · doi:10.1080/02841860310011131 · Cited by 107
Estimation of an optimal radiotherapy utilization rate for breast carcinoma
Delaney, G. P., Barton, M. B., & Jacob, S. (2003) · Cancer · doi:10.1002/cncr.11740 · Cited by 104
Self-citationAn evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer
Foroudi, F., Tyldesley, S. K., Walker, H. D., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02821-3 · Cited by 68
Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer
Foroudi, F., Tyldesley, S. K., Barbera, L. C., Huang, J., & Mackillop, W. J. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03866-x · Cited by 62
Variations in the management and outcome of non-small cell lung cancer in Ontario
Mackillop, W. J., Dixon, P., Zhou, Y., et al. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90096-5 · Cited by 51
Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma
Delaney, G. P., Jacob, S., & Barton, M. B. (2004) · Cancer · doi:10.1002/cncr.20444 · Cited by 50
Self-citationHow do we bring an acceptable level of radiotherapy services to a dispersed population?
Denham, J. W. (1995) · Australasian Radiology · doi:10.1111/j.1440-1673.1995.tb00264.x · Cited by 48
An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer
Foroudi, F., Tyldesley, S. K., Barbera, L. C., Huang, J., & Mackillop, W. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00423-1 · Cited by 46
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma
Delaney, G., Jacob, S., & Barton, M. (2005) · Cancer · doi:10.1002/cncr.21084 · Cited by 45
Self-citationEstimation of an optimal radiotherapy utilization rate for gynecologic carcinoma
Delaney, G. P., Jacob, S., & Barton, M. B. (2004) · Cancer · doi:10.1002/cncr.20445 · Cited by 42
Self-citationEstimation of an optimal radiotherapy utilization rate for melanoma
Delaney, G. P., Barton, M. B., & Jacob, S. (2004) · Cancer · doi:10.1002/cncr.20092 · Cited by 40
Self-citationRadiotherapy utilization in New South Wales from 1996 to 1998
Barton, M. B. (2000) · Australasian Radiology · doi:10.1046/j.1440-1673.2000.00833.x · Cited by 33
Self-citationDelaney, G. P., Barton, M. B., & Jacob, S. (2004) · Cancer · doi:10.1002/cncr.20443 · Cited by 29
Self-citationLote, K., Möller, T., Nordman, E., et al. (1991) · Acta Oncologica · doi:10.3109/02841869109092417 · Cited by 22
Clinical Practice Guidelines: Management of Advanced Breast Cancer
(2001) · PsycEXTRA Dataset · doi:10.1037/e509362012-001 · Cited by 21
Use of radiotherapy in the primary treatment of cancer in South Australia
Luke, C., Chapman, P., Priest, K., et al. (2003) · Australasian Radiology · doi:10.1046/j.0004-8461.2003.01144.x · Cited by 19
Radiotherapy utilization in New South Wales from 1996 to 1998: Comment
Kearsley, J. (2000) · Australasian Radiology · doi:10.1046/j.1440-1673.2000.00863.x · Cited by 10
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
Lei, G., Zhang, Y., Koppula, P., Liu, X., Zhang, J., Lin, S. H., Ajani, J. A., Xiao, Q., Liao, Z., Wang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-019-0263-3 · Cited by 1,318
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
Metadata
- Authors
- Delaney, G., Jacob, S., Featherstone, C., & Barton, M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-08-03
- Volume
- 104
- Issue
- 6
- Pages
- 1129-1137
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1484334610
- Cited by
- 1,727
- References
- 22
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.